Literature DB >> 477053

Incidence and significance of rising blood acetate levels during hemodialysis.

M A Mansell, T O Nunan, M F Laker, N A Boon, A J Wing.   

Abstract

Recent work suggests that rising arterial acetate levels occur in some patients undergoing hemodialysis and that they may be responsible for some dialysis problems, particularly cardiovascular instability. Blood acetate levels and acetate flux rates have been determined in 20 adult and 4 pediatric patients during hemodialysis as well as in 4 patients with combined renal and hepatic failure. Rising acetate levels occurred in 25% of the adult patients, although they were stable in the children and the patients with renal and hepatic failure. The occurrence of hypotension during dialysis was unrelated to a high blood acetate level.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 477053

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  4 in total

1.  Acetate or bicarbonate for haemodialysis?

Authors:  M A Mansell; A J Wing
Journal:  Br Med J (Clin Res Ed)       Date:  1983-07-30

Review 2.  Crystalloid fluid choice in the critically ill : Current knowledge and critical appraisal.

Authors:  Carmen A Pfortmueller; Barbara Kabon; Joerg C Schefold; Edith Fleischmann
Journal:  Wien Klin Wochenschr       Date:  2018-03-02       Impact factor: 1.704

3.  Alterations in brain glucose utilization accompanying elevations in blood ethanol and acetate concentrations in the rat.

Authors:  Robert J Pawlosky; Yoshihiro Kashiwaya; Shireesh Srivastava; Michael T King; Calvin Crutchfield; Nora Volkow; George Kunos; Ting-Kai Li; Richard L Veech
Journal:  Alcohol Clin Exp Res       Date:  2009-11-24       Impact factor: 3.455

4.  Fluid management in patients undergoing cardiac surgery: effects of an acetate- versus lactate-buffered balanced infusion solution on hemodynamic stability (HEMACETAT).

Authors:  Carmen A Pfortmueller; Livia Faeh; Martin Müller; Balthasar Eberle; Hansjörg Jenni; Björn Zante; Josef Prazak; Lars Englberger; Jukka Takala; Stephan M Jakob
Journal:  Crit Care       Date:  2019-05-06       Impact factor: 9.097

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.